This finding is consistent with our group’s earlier study where pretreatment with HJP 272 significantly reduced CXCL12 levels in bleomycin (Bleomycin)-induced pulmonary fibrosis animal models [38]. The gene discussed is CXCL12; the disease is pulmonary fibrosis.